Simponi approved for ulcerative colitis treatmentDrug is the first subcutaneous biological therapy to receive Health Canada approval for use in the management of ulcerative colitis. Do PPIs increase hip fracture risk?Gastroenterology group updates its position on proton pump inhibitor therapy and the risk of hip fracture. Humira now approved for Crohn’s disease in adolescents Drug is the first subcutaneous biologic to be approved in Canada for the treatment of Crohn's disease in children Clinical Notes: New oral anticoagulants increase GI bleeding risk New oral anticoagulants increase the risk of gastrointestinal bleeding, according to a recent systematic review and meta-analysis. Leading the Way in Gastrointestinal Care Steps to help optimize care in patients with GI conditions Heat waves hard on the gut IBD and pregnancy: Many misconceptions Both patients and doctors have things to learn IBD more severe in B.C.’s South Asian kids Patients have more aggressive disease and need stronger therapy sooner High-powered magnets wreak havoc on the GI tract Even older kids are swallowing them; surgery common MRI an option for colon screening? Technique has the advantage of avoiding radiation exposure First Previous 15 16 17 18 19 Next Last